Selpercatinib and Body Composition

N/ACompletedNCT07543887

University of Pisa15 enrolled

Overview

investigation of body composition

investigation of body composition by DXA

Study Type

OBSERVATIONAL

Enrollment

Conditions

Thyroid Cancer

Interventions

observation in patient under treatmentOTHER

observation in patient under treatment

SelpercatinibDRUG

observational study of patients under selpercatinib

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Adults (≥18 years old) * Diagnosis of thyroid cancer * Ongoing treatment with selpercatinib Exclusion Criteria: \- Inability to provide informed consent

Locations (1)

University Hospital of Pisa

Pisa, PI, Italy

Outcomes

Primary Outcomes

Total lean mass assessed by DXA (kg)

Total lean body mass measured by dual-energy X-ray absorptiometry

Time frame: Baseline and 12 months

Secondary Outcomes

24-hour energy expenditure (kcal/day)

Total energy expenditure measured over 24 hours using a whole-room indirect calorimeter

Time frame: Baseline and 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.